Clinical trial
An Observational Study of Patients With Coronavirus Disease 2019
NCT04331886 is registered in ClinicalTrials.gov with Target PharmaSolutions, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Observational Study of Patients With Coronavirus Disease 2019
- Lead sponsor
- Target PharmaSolutions, Inc.
- Phase
- Observational
- Overall status
- Completed
- Start date
- April 13, 2020
- Completion date
- September 26, 2022
- Enrollment
- 199 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
coronavirus, covid-19